Anodyne

DOPA, L-DOPA
Generated by the Chemistry Development Kit (http://github.com/cdk)
Molecular structure via molpic based on CDK
Physical properties
[]
197.19 g/mol [1]
AppearanceColorless to white crystals or crystalline powder; needles from water [1]
OdorOdorless [1]
TasteTasteless [1]
Melting point284-286 °C [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubility5mM [1]
-2.7 [1]
Structural Identifiers
[]
C9H11NO4 [1]
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid [1]
C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O [1]
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1 [1]
InChIKeyWTDRDQBEARUVNC-LURJTMIESA-N [1]
Pharmacokinetics[]
Elimination half-life0.75 – 1.5 hours

3,4-Dihydroxyphenylalanine

3,4-Dihydroxyphenylalanine is a substance of the amino acid and catecholamine class.

Chemistry

 []

3,4-Dihydroxyphenylalanine is a absolute mixture

Anodyne Usernotes
[]
0xea / 3,4-Dihydroxyphenylalanine via Oral
  • subjective locomotor-activity increase; subjective mood-improvement

Legal status []

  • Australia: 3,4-Dihydroxyphenylalanine is a S4 substance.
  • United Kingdom: 3,4-Dihydroxyphenylalanine is a prescription only substance.
  • United States: 3,4-Dihydroxyphenylalanine is a prescription only substance.
  • European Union: 3,4-Dihydroxyphenylalanine is a prescription only substance.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 6047, Levodopa. Accessed November 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/6047

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 3,4-Dihydroxyphenylalanine. UNII: 46627O600J. Global Substance Registration System. Accessed November 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/46627O600J